News

December 8, 2017

Lab Online

Upstream Medical Technologies has developed a biomarker-based diagnostic test to rule out the risk of imminent heart attack.

For the full article go here

Share this post

More Articles

Detecting at-risk heart attack patients, a step closer with $2m investment

Upstream Medical Technologies, a leading deep-tech company focused on developing innovative solutions for heart disease, announced today that it has closed a significant capital round to further advance its frontline diagnostic tests for cardiac diseases.

Upstream commences testing Marker C on the APACE cohort

The next phase of development is now underway, with the commencement of testing Marker C on the APACE cohort.

December 12, 2022

Analysis of Marker C in clinical triage protocols available

By shifting chest pain patients with intermediate troponins to low or high-risk categories, Marker C could rapidly triage 10-35% more chest pain patients in the emergency department.

Connect with us

info@upstreamdx.com

Auckland, New Zealand